CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Clinical trial NCT03904251 · TERMINATED
Trial details
- NCT number
- NCT03904251
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2023-10-25
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.